Follow
Ravikiran Panakanti
Ravikiran Panakanti
Associate Professor of Pharmaceutics, Roosevelt University
Verified email at roosevelt.edu
Title
Cited by
Cited by
Year
Impact of excipient interactions on drug bioavailability from solid dosage forms.
NAS Panakanti R
Pharmaceutical Research 29 (10), 2012
1132012
Attenuation of early liver fibrosis by pharmacological inhibition of smoothened receptor signaling
A Pratap, S Singh, V Mundra, N Yang, R Panakanti, JD Eason, RI Mahato
Journal of drug targeting 20 (9), 770-782, 2012
512012
Cyclopamine attenuates acute warm ischemia reperfusion injury in cholestatic rat liver: hope for marginal livers
A Pratap, R Panakanti, N Yang, R Lakshmi, KA Modanlou, JD Eason, ...
Molecular pharmaceutics 8 (3), 958-968, 2011
432011
XIAP gene expression protects β-cells and human islets from apoptotic cell death
H Wu, R Panakanti, F Li, RI Mahato
Molecular pharmaceutics 7 (5), 1655-1666, 2010
362010
Inhibition of endogenous hedgehog signaling protects against acute liver injury after ischemia reperfusion
A Pratap, R Panakanti, N Yang, JD Eason, RI Mahato
Pharmaceutical research 27, 2492-2504, 2010
342010
Bipartite vector encoding hVEGF and hIL-1Ra for ex vivo transduction into human islets
R Panakanti, RI Mahato
Molecular pharmaceutics 6 (1), 274-284, 2009
342009
Bipartite adenoviral vector encoding hHGF and hIL-1Ra for improved human islet transplantation
R Panakanti, RI Mahato
Pharmaceutical research 26, 587-596, 2009
292009
Triplex forming oligonucleotides against type α1 (I) collagen attenuates liver fibrosis induced by bile duct ligation
R Panakanti, A Pratap, N Yang, JS Jackson, RI Mahato
Biochemical pharmacology 80 (11), 1718-1726, 2010
242010
Evaluation of an undocumented polyherbal (Faradin®) used for the treatment of sickle cell disease in West Africa. Part I: Phytochemistry and ex-vivo anti-sickling study
M Adeyeye, D Gbadero, L Farayola, N Olalere, R Panakanti, I Rajab, ...
British Journal of Pharmaceutical Research 17 (1), 1-14, 2017
32017
Diabetes Mellitus-Islet Transplantation & Gene Therapy.
R Panakanti
SM Journal of pharmacology and Therapeutics 3 (1), 2017
12017
Intraspecies allometric equations derived using phase 1 clinical adult pharmacokinetic parameters for pediatric dosing of lamivudine, nevirapine, and zidovudine
AS Adebayo, R Panakanti
Journal of Applied Pharmaceutical Science 12 (8), 026-035, 2022
2022
Hepatocyte Growth Factor and Betacellulin Gene Expression for Treating Diabetes: In vitro analysis.
Y Desai, M Patel, R Panakanti
International Journal of Pharmaceutical Investigation 12 (1), 2022
2022
Liver Fibrosis-Novel Therapy Perspective
R Panakanti
Open Access Journal of Pharmaceutical Research 1 (7), 2017
2017
Recent Advances in Gene Expression and Delivery Systems
R Panakanti, RI Mahato
Targeted Delivery of Small and Macromolecular Drugs, 83, 2010
2010
Therapeutic gene delivery to human pancreatic islets for treatment of diabetes and the effect of TFO on liver fibrosis induced by bile duct ligation
R Panakanti
The University of Tennessee Health Science Center, 2010
2010
Development of Controlled Release Metformin Tablet and its Estimation Using a New HPLC Assay
AS Adebayo, R Panakanti, N Venkatesan, C Popescus, M Adeyeye
The system can't perform the operation now. Try again later.
Articles 1–16